Eloisa Arbustini is an expert in Cardiology at Policlinico San Matteo Fondazione (Italy). As of October 2026, ScienceLeadR ranks Eloisa Arbustini in the top 1% of experts worldwide for Cardiomegaly and Cardiomyopathies, and in the top 1% of experts in Italy for Genetic Services. Eloisa Arbustini has authored 597 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 3 of them ongoing. SLR score: 2,094 (community average: 125). How the SLR is computed.

LeadR Profile

2 094 ScienceLeadR Reputation 2094
Network Map

Cardiology

Subspecialties: Genetics - Transplantation - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026

Source: PubMed

Fondazione IRCCS Policlinico San Matteo

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 597

Citations

Citations: 36 816 1st author: 114 Last author: 140 Unique author: 6


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Rapid genomic analysis for early identification of complement abnormalities in adults with transplant-associated thrombotic microangiopathy.
PMID 42531779 — thrombotic microangiopathies, cells, genes, blood, diagnosis, transplants, nanopore sequencing, complement system proteins, cell transplantation, complement activation, transplantation, nanopores
Hematol Transfus Cell Ther20260
Right Atrial Cardiac Calcified Amorphous Tumors in Young Women: Two Case Reports and a Narrative Review of the Literature.
PMID 42505889 — embolism, vena cava, superior, neoplasms, echocardiography, kidney failure, chronic
J Cardiovasc Dev Dis20260
Lack of Pathogenic Variants in Master Endurance Athletes with Aortic Dilatation Identified with Echocardiographic Screening.
PMID 42480889 — genetics, cardiology, athletes
Am J Cardiol20260
Long-term prognostic impact of optical coherence tomography detected plaque rupture in nonculprit coronary segments.
PMID 42297530 — tomography, arteriosclerosis, tomography, optical coherence, rupture
Atherosclerosis20261
Evaluation of genetic-molecular causes of out-of-hospital cardiac arrest - from patients to families: the GenetiCA study.
PMID 42199521 — heart diseases, out-of-hospital cardiac arrest, public health, aged, heart arrest, environmental pollution, cardiomyopathies
Resusc Plus20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Chair: 1

By phase:

N/A 6
Phase 3 1

By status:

Recruiting 4
Unknown 2
Active not recruiting 1

By type:

Observational 4
Interventional 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 4

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Evaluation of Genetic molecular Causes of Out of Hospital Cardiac Arrest From Patients to Families
NCT06844851 — heart diseases, resuscitation, heart, cardiovascular diseases, out-of-hospital cardiac arrest, heart arrest, environmental pollution
N/ARecruiting2021
Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy the CVRISK IT Trial (CVRISK IT)
NCT06832644 — chronic disease, life style, cardiovascular diseases, primary prevention, therapeutics, men
N/ARecruiting2025
Italian Digital Primary Cardiovascular Prevention Study
NCT05339841 — diabetes mellitus, hypertension, life style, algorithms, mobile applications, risk factors, primary prevention, empowerment, hypercholesterolemia, digital health
N/AActive not recruiting2022

LeadR Networks

Main global connection map